NEUROPACE INC's ticker is NPCE and the CUSIP is 641288105. A total of 26 filers reported holding NEUROPACE INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 3.2%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KCK LTD. | 5,621,111 | $54,693,410 | 77.70% |
Soleus Capital Management, L.P. | 2,466,205 | $23,996,175 | 2.21% |
Kent Lake Capital LLC | 574,417 | $5,589,077 | 2.15% |
Nantahala Capital Management | 1,219,915 | $11,869,773 | 1.01% |
Orbimed Advisors | 4,012,281 | $39,039,494 | 0.83% |
EAM Investors, LLC | 141,616 | $1,377,924 | 0.27% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 60,048 | $584,267 | 0.01% |
Financial Advocates Investment Management | 10,000 | $97,300 | 0.01% |
MORGAN STANLEY | 2,399,716 | $23,349,237 | 0.00% |
FMR LLC | 706,245 | $6,871,765 | 0.00% |
Renaissance Technologies | 44,285 | $431 | 0.00% |
MILLENNIUM MANAGEMENT LLC | 184,169 | $1,791,964 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 110,209 | $1,072,591 | 0.00% |
STATE STREET CORP | 33,251 | $323,532 | 0.00% |
CITIGROUP INC | 2,984 | $29,034 | 0.00% |
BlackRock Inc. | 59,968 | $583,488 | 0.00% |
Qube Research & Technologies Ltd | 2,399 | $23,342 | 0.00% |
BARCLAYS PLC | 10,839 | $105 | 0.00% |
ROYAL BANK OF CANADA | 4 | $0 | 0.00% |
External links
This page lists NEUROPACE INC's shareholders in Q3 2023. To view NEUROPACE INC's shareholder history, click here.